Literature DB >> 28212924

IBD immunopathogenesis: A comprehensive review of inflammatory molecules.

Jae Hyon Park1, Laurent Peyrin-Biroulet2, Michael Eisenhut3, Jae Il Shin4.   

Abstract

Inflammatory molecules play a crucial role in the pathogenesis of inflammatory bowel disease (IBD) such as ulcerative colitis and Crohn's disease, both of which are chronic inflammatory conditions of the gastrointestinal tract. Abnormal expressions of pro- and anti-inflammatory molecules have been described to cause an imbalance to the gut innate and adaptive immunity, and recently a large portion of research in IBD has been geared towards identifying novel molecules that may be used as potential therapeutic targets. Understanding of these inflammatory molecules has suggested that although ulcerative colitis and Crohn's disease share many common clinical symptoms and signs, they are in fact two separate clinical entities characterized by different immunopathogenesis. In this review, we comprehensively discuss the roles of numerous inflammatory molecules including but not limited to cytokines, chemokines, inflammasomes, microRNAs and neuropeptides and their expression status in ulcerative colitis and Crohn's disease in relation to their effects on the overall intestinal inflammatory process.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28212924     DOI: 10.1016/j.autrev.2017.02.013

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  74 in total

1.  Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.

Authors:  Steven J Edwards; Samantha Barton; Mariana Bacelar; Charlotta Karner; Peter Cain; Victoria Wakefield; Gemma Marceniuk
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

Review 2.  The parallel paradigm between intestinal transplant inflammation and inflammatory bowel disease.

Authors:  Leonid Belyayev; Katrina Loh; Thomas M Fishbein; Alexander Kroemer
Journal:  Curr Opin Organ Transplant       Date:  2019-04       Impact factor: 2.640

Review 3.  Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Jurij Hanzel; Christopher Ma; Niels Vande Casteele; Reena Khanna; Vipul Jairath; Brian G Feagan
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

4.  Effects of Cyclophosphamide and/or Doxorubicin in a Murine Model of Postchemotherapy Cognitive Impairment.

Authors:  Timothy J Flanigan; Julie E Anderson; Ikram Elayan; Antiño R Allen; Sherry A Ferguson
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

Review 5.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 6.  Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.

Authors:  Eleni Stylianou
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

7.  Murine Adherent and Invasive E. coli Induces Chronic Inflammation and Immune Responses in the Small and Large Intestines of Monoassociated IL-10-/- Mice Independent of Long Polar Fimbriae Adhesin A.

Authors:  Julia M Schmitz; Susan L Tonkonogy; Belgin Dogan; Anna Leblond; Kristi J Whitehead; Sandra C Kim; Kenneth W Simpson; R Balfour Sartor
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

8.  Simultaneous quantitative profiling of clinically relevant immune markers in neonatal stool swabs to reveal inflammation.

Authors:  Veronika Vidova; Eliska Benesova; Jana Klanova; Vojtech Thon; Zdenek Spacil
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

9.  The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target.

Authors:  Ankit Verma; Srinivas Pittala; Belal Alhozeel; Anna Shteinfer-Kuzmine; Ehud Ohana; Rajeev Gupta; Jay H Chung; Varda Shoshan-Barmatz
Journal:  Mol Ther       Date:  2021-07-02       Impact factor: 11.454

10.  Flower extract of Caragana sinica. ameliorates DSS-induced ulcerative colitis by affecting TLR4/NF-κB and TLR4/MAPK signaling pathway in a mouse model.

Authors:  Ting Li; Qiu-Ping Zou; Feng Huang; Gui-Guang Cheng; Ze-Wei Mao; Ting Wang; Fa-Wu Dong; Bao-Jing Li; Hong-Ping He; Yan-Ping Li
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.